BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Net other income and expenses outside core operations
Latest
$-73.60M
↓ 75% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-42.00M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-73.60M | +12.8% |
| 2024 | $-84.41M | +31.1% |
| 2023 | $-122.52M | -27.7% |
| 2022 | $-95.95M | -2246.5% |
| 2021 | $-4.09M | +49.2% |
| 2020 | $-8.06M | +14.7% |
| 2019 | $-9.44M | -34.3% |
| 2018 | $-7.03M | +16.0% |
| 2017 | $-8.37M | -28.1% |
| 2016 | $-6.54M | - |